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Background: This study aimed at understanding whether investigators from less wealthy countries were at a dis-
advantage in disseminating their research, after accounting for potential differences in research quality and infra-
structure.
Methods and Results: In this bibliometric analysis a representative random selection of 10% (n = 1002 studies) of
all abstracts submitted to the European Society of Cardiology (ESC) congress 2006 was followed for publication
and citation from September 2006 to December 2011. The main variable of interest was the per-capita gross do-
mestic product (GDP) of the country of the principal investigator. Using multivariable models that adjusted for
socioeconomic indicators and previously identiﬁed markers of research quality, we examined the relationship
between per-capita GDP and three study endpoints: Acceptance at the ESC congress, full-text publication, and
number of two-year citations. Among 1002 abstracts from 63 countries, per-capita GDPwas positively correlated
with all three study endpoints. After adjusting for markers of research quality and infrastructure, per-capita GDP
remained a strong predictor for acceptance at the ESC congress (adjusted OR for every 10,000 USD increase in
per-capita GDP, 1.44; 95% CI, 1.15 to 1.80), full-text publication within 5 years (adjusted OR, 1.49; 95% CI, 1.17
to 1.90), and high citation frequency (adjusted OR, 2.30; 95% CI, 1.31 to 4.04). These ﬁndingswere largely consis-
tent in a subgroup of abstracts of high-quality, prospective clinical trials.
Conclusion: Investigators in less wealthy countries face challenges to disseminate their research, even after
accounting for potential differences in the quality of their work and research infrastructure.© 2013 The Authors. Published by Elsevier Ireland Ltd. Open access under CC BY-NC-SA license.liability and freedom from bias
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Economic indicators have been correlated with scientiﬁc productiv-
ity with a gap between poor and wealthy nations [1–3]. Although the
mechanism for this observation remains unknown, it has been postulat-
ed that much of this gap may be a result of less research infrastructure,
education, and training to perform high-quality work in poor nations
[1,4]. A potential bias in the dissemination of research from investiga-
tors in poor nations also has been suggested, but there is little empirical
evidence to support it [4–7].
Our objectivewas to better understand if and how thedissemination
of research may be inﬂuenced by the wealth of the country in which itC-SA license.
191S. Winnik et al. / International Journal of Cardiology 169 (2013) 190–195was produced. Thus, we studied the abstracts submitted to the
European Society of Cardiology (ESC) congress in 2006, and followed
the fate of a randomly selected sample of 1002 studies over ﬁve years.
A distinct advantage of this approach over earlier studies [3,16,17]
was the opportunity to dissect differences in study design and other pu-
tative markers of research quality and infrastructure, thereby isolating
the effect of wealth on the dissemination of research. It also allowed
us to evaluate the process of research dissemination along a continuum
from acceptance at amajor scientiﬁcmeeting to subsequent publication
to citations following full-text publication. Finally, this approach lever-
aged a unique aspect of the ESC congress by allowing us to examine
the impact of national wealth across a broad range of countries that in-
cluded both developing and developed countries.
We anticipate that our ﬁndings will increase the awareness and may
improve theunderstanding of potential challenges faced by investigators
from less wealthy nations in the dissemination of their research, and
may help to determine potential solutions to address these concerns.
2. Methods
2.1. Study design
All abstracts submitted to the ESC congress 2006 (n = 10,020) were retrieved and a
representative random sample of 10% (n = 1002, margin of error 0.01) [8] was analyzed
according to pre-speciﬁed variables including known predictors of scientiﬁc impact [9]. A
ﬁve-year bibliometric follow-up for full-text publication in peer-reviewed journals and
the number of two-year citations, together with acceptance at congress-level, served as
parameters for the successful dissemination of research [10,11]. Multivariable logistic re-
gression analyses were performed to quantify the predictive value of economic indicators
on successful dissemination of research after adjusting for putativemarkers of research in-
frastructure, quality or impact.
2.2. Data collection
The reliability of the computer-assisted representative randomselectionwas assessed
and conﬁrmed through comparisons of the distribution of the variables common to both
the original sample of all 10,020 abstracts and the randomly selected sample of 1002
abstracts. As described, no differences in the distribution of common variables were
observed [9].
All abstracts within the representative subsample (n = 1002) were assessed by one
out of four independent reviewers (SW, DAR, JHW, MH) according to a set of pre-
speciﬁed variables including markers of scientiﬁc impact as detailed in the web extra ma-
terial. In an initial pilot study a random sample of 3% of the study sample (n = 30) was
assessed independently by each of the four reviewers to address inter-observer variances.
Fleiss' kappa valueswere 0.853 or above (categorical variables) and intra-class correlation
coefﬁcients (metric variables) were 0.996 or higher [9].
Socioeconomic indicators including the per-capita gross domestic product (GDP, in
current U.S. dollars) of the country of the last author (considered the respective principal
investigator), national expenditures on education, research and development, as well as
the number of researchers per country were retrieved from the World Bank Data Cata-
logue (World Development Indicators) [12]. All indicators refer to the year 2006 to ap-
praise the economic conditions under which the research submitted to the ESC congress
2006 was performed. We chose per-capita GDP for the following reason: Referring to
the market value of goods and services produced within a country in a given period of
time the GDP allocates production based on physical location as opposed to national own-
ership. Therefore, it serves better to appraise the physically existingwealth of a country in
comparison to the gross national product (GNP), which allocates production based on
ownership of national accounts.
2.3. Bibliometric follow-up
We followed the cohort of abstracts for ﬁve years for full-text publication in peer-
reviewed journals and the number of subsequent two-year citations, beginning at the
time of publication. Acceptance at congress level, publication – in conjunctionwith the im-
pact factor of the journal of publication – and the number of two-year citations served as
parameters for successful research dissemination [10,11,13]. Identiﬁcation of published
articles was achieved using a step-wise search algorithm as described [9]. Brieﬂy, the full
or simpliﬁed abstract title, in conjunction with the names of ﬁrst and last author, or the
last author alone, were used as search terms in PubMed®, Google Scholar or Google in
this order. Thus, articles published in journals not indexed in PubMed® were also re-
trieved. All full-text publications identiﬁed were published in peer-reviewed journals
indexed in PubMed® (Table S2). Validation of identiﬁed articles was accomplished
through the comparison of the respective endpoints, the number and size of study groups,
and the conclusion as described in the web extra material. The number of two-year cita-
tions was determined using the citation indexing and search service of the ISI Web of
Science (Thomson Reuters).2.4. Statistical analyses
Uni- and multivariable binary logistic regression analyses were performed for the de-
pendent variables “acceptance at congress level”, “full-text publication”, “publication in
scientiﬁc journals with an impact factor above the 75th percentile of journals where
these works were submitted (i.e., N5.36)”, and a “two-year citation rate above the 75th
percentile of this study cohort (i.e., N6 citations)”. The following variables were entered
into the ﬁnal model: Type of research (basic vs. clinical), study design of clinical research
(randomized controlled trials vs. prospective non-randomized data collections vs. retro-
spective studies vs. systematic reviews vs. meta-analyses vs. other), number of enrolled
patients (≥100 vs. b100), topic of research (rhythmology vs. heart failure vs. coronary
artery disease vs. interventional cardiology vs. prevention and epidemiology vs. hyperten-
sion, peripheral artery diseases and cardiovascular surgery vs. other), continent of origin of
the last author, genders of ﬁrst and last authors, national expenditures on research andde-
velopment, on education, number of researchers per million inhabitants, and per-capita
GDP. To determine the goodness of ﬁt of the ﬁnal model, c-statistics were calculated.
Collinearity between related explanatory variables (such as the national expenses on re-
search and development and the per-capita GDP) were assessed using progressively
segregated groups of variables in four regression analyses for each endpoint (Table S5).
In a sensitivity analysis, countries of the lowest per-capita GDP group (b10,000 USD)
were excluded to assure that ﬁndingswere not driven disproportionately by these nations
(Table S3). A second sensitivity analysis was conducted to ascertain that the use of ﬁrst as
opposed to last author origin of randomized controlled trials did not signiﬁcantly impact
on the results (Table S4). p values were two-sided and considered statistically signiﬁcant
for p b 0.05. Statistical analyses were performed using IBM SPSS Statistics 20.
3. Results
3.1. Geographic distributions of wealth and research dissemination
are similar
10,020 abstracts were submitted to the ESC congress 2006 from
63 different countries. National per-capita gross domestic products
(GDP) of the submitting countries ranged from less than 1000 USD
(e.g., India) to over 70,000 USD (e.g., Norway) (Fig. 1, Table S1). For
nations with a medium to high scientiﬁc activity (abstract submis-
sion rates above one per million inhabitants) markers of successful
research dissemination (i.e. abstract acceptance at the ESC congress,
subsequent publication in peer-reviewed journals, and later citation)
followed a similar distribution compared with economic indicators
(i.e. the per-capita GDP and expenditures on Research and Development)
(Fig. 1).
3.2. GDP-based stratiﬁcation of submitting nations associates wealth with
research dissemination
When stratifying submitted studies to four per-capita GDP groups
(b10,000 USD [low], 10,000–20,000 USD [medium], N20,000–30,000
USD [high], N30,000 [very high]) the following observations were
made: Most abstracts originated from very wealthy or very poor coun-
tries, only few from those in between. Acceptance rates at the ESC con-
gress, publication rates, and subsequent two-year citation rates rose in
parallel with per-capita GDP. The highest proportion of published stud-
ies in the top 25% journals (according to their impact factor) was
reached by studies submitted from countries with the highest per-
capita GDP and vice versa (Fig. 2).
3.3. Per-capita GDP is an independent predictor of successful research
dissemination in cardiology
Using univariate logistic regression analyses, per-capita GDP was
found to predict scientiﬁc success at all three levels of the process or re-
search dissemination (Table 1). After adjusting for putativemarkers of re-
search quality and infrastructure, including type of research (clinical vs.
basic), study design, number of enrolled patients, studyﬁeld, institutional
afﬁliation, number of researchers per million inhabitants, and national
expenditures on education, as well as on research and development,
per-capita GDP remained a strong predictor of research dissemination:
for every 10,000 USD increase in per-capita GDP there was a 44% in-
creased chance for acceptance at the ESC congress (OR = 1.44, 95%
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Fig. 1.Qualitative assessment of economic prosperity and scientiﬁc performance in Europe. (A) Per-capita gross domestic products 2006. (B) Expenditures on research and development
2006. (C) Number of abstracts submitted to the ESC congress 2006. (D–F) Acceptance, subsequent full-text publication and 2-year citation rates.
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reviewed journal (OR = 1.49, 95% CI = 1.171–1.903), a 269% increased
chance for publishing in one of the top 25% of journals per impact factor
(OR = 3.69, 95% CI = 1.660–8.239), and a 130% increased chance to
reach the top 25% two-year citation rate (OR = 2.30, 95% CI = 1.312–
4.037) (Table 1).
To assess the association between national wealth and research dis-
semination speciﬁcally in high-quality clinical research, a subgroup anal-
ysis was performed involving only prospective clinical trials (n = 357,
Table 2). In this subgroup, per-capita GDPwas an even stronger predictor
for research dissemination at the levels of full-text publication in a peer-
reviewed journal, and publication in one of the top 25% journalsaccording to their impact factor. Due to the low number of published
studies that reached the top 25% two-year citation rates (n = 69) signif-
icancewas not reached at the citation level, though results trended in the
same direction. When adjusting for markers of study quality including
known predictors of scientiﬁc impact in cardiovascular research, for
every 10,000 USD increase in the per-capita GDP there was a 64% in-
creased chance for publishing in a peer-reviewed journal (OR = 1.64,
95% CI = 1.101–2.445), and a 351% increased chance for publishing in
a journal among the top 25% (OR = 4.51, 95% CI = 1.168–17.417)
(Table 2C). These ﬁndings suggest an even stronger independent corre-
lation of the per-capita GDPwith researchdissemination in the subgroup
of prospective clinical trials.
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Fig. 2. Stratifying research dissemination according to national wealthwithin the ESC congress 2006. Submission, acceptance, full-text publication, and 2-year citation rateswere stratiﬁed
into four groups based onper-capita gross domestic products (GDP). Percentages (gray) refer to the respective GDP category, (n) to thenumber of abstracts, italic numbers represent those
studies initially accepted at the ESC congress.
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4.1. Principal ﬁndings
Our study reveals that economic strength predicts scientiﬁc perfor-
mance on all key steps of the generation and dissemination of scientiﬁc
knowledge, independent of known predictors of scientiﬁc impact or re-
search infrastructure [9]. After adjusting for origin and type of research,
study design, number of enrolled patients, study ﬁeld, institutional afﬁl-
iation, author gender, andmarkers of research infrastructure, per-capita
GDP remained a strong predictor for research dissemination from ab-
stract acceptance to full-text publication, and subsequent citation. An
increase of the per-capita GDP in 10,000 USD increased overall chances
for publication in one of the top 25% peer-reviewed journals by 269%.
As a concrete example of what these latter ﬁndings indicate, an RCT
lead by a principle investigator in The Netherlands was over 350%more
likely to be published in one of the top 25% journals compared with an
RCT including the same number of patients, in the same research ﬁeld,
by an investigator at a similar institution, located in Spain; chances
rose to over 700% when compared with an RCT lead by an investigator
e.g. in the Czech Republic or Portugal.4.2. Strengths of this study and important differences to previous studies
To our knowledge this is the ﬁrst study in which associations be-
tween economic indicators and scientiﬁc performance have been ad-
justed for widely accepted markers of research quality, such as study
design or the number of enrolled patients in clinical trials [14,15]. The
conception that the interdependence of economic strength and scientif-
ic performance may be due alone to the fact that large trials with an
elaborate and costly design cannot be performed in economically less
powerful countries is challenged. Our results are based on a ﬁve-year
bibliometric follow-up of a cohort of cardiovascular studies representa-
tive for over 10,000 abstracts from 63 different countries.
Most previous studies are based on only one level of research dis-
semination such as the number of published documents and/or the im-
pact factor of the journals in which the research was published
[2,3,16,17]. In this study, three different levels of dissemination of scien-
tiﬁc knowledge, i.e. acceptance at the ESC congress 2006, publication in
peer-reviewed journals (including the respective impact factor), and
the subsequent study-speciﬁc citation rates have been assessed sepa-
rately. Therefore, our results are based on a more detailed assessment
of scientiﬁc performance.
Table 1
The gross domestic product (GDP) as predictor of scientiﬁc performance in cardiovascular
science.
p value OR (95% CI) c-stat
A. Acceptance at congress-level
Crude b0.001 1.386 (1.263–1.520) 0.515
Adjusted 0.001 1.440 (1.150–1.802) 0.598
B. Publication in a peer-reviewed journal
Crude b0.001 1.387 (1.256–1.532) 0.498
Adjusted 0.001 1.493 (1.171–1.903) 0.541
C. Impact factor ≥5.36
Crude b0.001 1.707 (1.319–2.210) 0.507
Adjusted 0.001 3.689 (1.660–8.239) 0.623
D. Two-year citations ≥6
Crude 0.001 1.473 (1.177–1.844) 0.506
Adjusted 0.004 2.301 (1.312–4.037) 0.655
Binary logistic regression analyses; accepted and rejected studies were followed for ﬁve
years for publication and two-year citation rates. The per-capita gross domestic product
(GDP) of each of the 63 submitting countries at the time of abstract submission (2006)
served as surrogate for economic strength. Analyses were adjusted for the following
parameters: the type of research (clinical vs. basic), the number of enrolled patients
(≤100 or more), the study design, the study ﬁeld, the continent of origin, academic afﬁli-
ation of the originating institution, ﬁrst and last author gender, national expenditures on
education, on research and development, and the number of researchers per million in-
habitants. Dependent variables were (A) acceptance at the ESC congress 2006, (B) full-
text publication in a peer-reviewed journal, (C) publication in one of the top 25% journals
according to impact factor (i.e. N5.36), and (D) reaching the top 25% two-year citation fre-
quency (i.e. N6 two-year citations). All analyses are based on a representative 10% selec-
tion (n = 1002) of all abstracts submitted to the ESC congress 2006. OR = odds ratio,
CI = conﬁdence interval, and c-stat = c-statistic.
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scientiﬁc congress, i.e. a level before full-text publication. Considering
that 55% of biomedical research abstracts submitted to a scientiﬁcmeet-
ing remain unpublished after six years [18,19] (in case of the ESC con-
gress 2006 71% remained unpublished after ﬁve years) [9] most
previous studies focusing on published documents failed to assess a
large proportion of the research that has in reality been performed.Table 2
The GDP as predictor of scientiﬁc success for prospective clinical studies in cardiology— a
subgroup analysis.
p value OR (95% CI) c-stat
A. Acceptance at congress-level
Crude b0.001 1.415 (1.206–1.660) 0.552
Adjusted 0.074 1.379 (0.970–1.961) 0.653
B. Publication in a peer-reviewed journal
Crude b0.001 1.573 (1.309–1.980) 0.510
Adjusted 0.015 1.641 (1.101–2.445) 0.607
C. Impact factor ≥5.36
Crude 0.005 1.825 (1.201–2.776) 0.516
Adjusted 0.029 4.509 (1.168–17.417) 0.708
D. Two-year citations ≥6
Crude 0.148 1.267 (0.919–1.745) 0.508
Adjusted 0.107 2.186 (0.846–5.654) 0.686
Binary logistic regression analyses; subgroup analyses including prospective clinical trials
only (n = 357). Accepted and rejected studieswere followed for ﬁve years for publication
and two-year citation rates. The per-capita gross domestic product (GDP) of each of the 63
submitting countries at the time of abstract submission (2006) served as surrogate for eco-
nomic strength. Analyseswere adjusted for the following parameters: the type of research
(clinical vs. basic), the number of enrolled patients (≤100 or more), the study design, the
study ﬁeld, the continent of origin, academic afﬁliation of the originating institution, ﬁrst
and last author gender, national expenditures on education, on research and development,
and the number of researchers per million inhabitants. Dependent variables were
(A) acceptance at the ESC congress 2006, (B) full-text publication in a peer-reviewed jour-
nal, (C) publication inone of the top25% journals according to impact factor (i.e. N5.36), and
(D) reaching the top 25% two-year citation frequency (i.e. N6 two-year citations). All anal-
yses are based on a representative 10% selection (n = 1002) of all abstracts submitted to
the ESC congress 2006. OR = odds ratio, CI = conﬁdence interval, and c-stat = c-statistic.Follow-up of this share is of particular interest when comparing regions
of different scientiﬁc activity and performance.
Taken together, the size and global distribution of this well-
characterized study cohort, along with the multi-leveled assessment
of research dissemination provide a novel perspective on the role of
the wealth of nations in the dissemination of research.
4.3. Potential limitations
Our study needs to be interpreted in the context of the following
limitations: Though widely accepted as neutral and quantitative indica-
tor of scientiﬁc performance [10,11,20–22], citation analyses may be
subject to bias. Having also assessed acceptance at congress level, pub-
lication per se, as well as the impact factor of the journal of publication,
we consider citation analysis as an adequate tool to complement the
other endpoints. Not all citation peaks may be covered in the applied
two-year citation window. However, in the rapidly moving ﬁeld of bio-
medical research, most citations peak within the ﬁrst two years after
publication [13,23].
There may be other determinants of research quality, such as scien-
tiﬁc originality, thatwere not assessed in this study. Their role cannot be
determined by our analyses but may have impacted on dissemination.
Moreover, the low numbers of abstract submissions from certain coun-
tries limit conclusions about the scientiﬁc performance of these coun-
tries. Yet this limitation itself provides unique insights. For example,
despite its comprehensive nature, this study remains unable to com-
ment on research from the Arabian Peninsula. Though per-capita GDP
is largely similar compared with western developed countries, no ab-
stract from this region in the world was among the cohort investigated
in this study. Importantly, the potential reasons for the observed results
and accordingly their implications discussed in this manuscript have
not been scientiﬁcally assessed at this stage, and therefore remained
speculative. Finally, data reported in this study refer speciﬁcally to car-
diovascular research. Extrapolation to other ﬁelds beyond cardiovascu-
lar science may be inaccurate.
4.4. Possible explanations
Investigators in lesswealthy countries still face challenges to publish
and disseminate their research, even after accounting for potential dif-
ferences in the quality of their work or research infrastructure. Interest-
ingly, theseﬁndings appear to apply beyonddeveloping countries: They
also seem to hold true in western nations in Europe or North America,
where per-capita GDP ranged from below 10,000 USD as in Poland or
Mexico to over 50,000 USD as in Switzerland or Norway.
Thus, we propose the following possible explanations for our
ﬁndings:
1) The wealth of nations may be a determinant of other markers affecting
scientiﬁc success. These may include investigators' experience and
track record, the density and quality of education facilities, English
language proﬁciency, the possibility of postgraduate training abroad,
the degree of international collaborations, or the accessibility to pub-
lished literature. If diminished, all these factorsmay negatively affect
educational advancement of researchers and manuscript quality.
Difﬁcult-to-read manuscripts may in turn trouble reviewers and
conceal scientiﬁc content, and thus lead to premature rejection of
potentially relevant studies.
2) Research from lesswealthy nationsmay appear less relevant, thus inter-
fering with its dissemination. Most high-ranking journals including
the majority of their reviewers are based in western, economically
privileged countries. Studies performed in very different surround-
ings on subjects of a different ethnic background may appear less
relevant to reviewers or editors. Judgments alike may not always
be seen in the light of an international readership in an increasingly
195S. Winnik et al. / International Journal of Cardiology 169 (2013) 190–195global scientiﬁc community and western populations of increasing
ethnic diversity.
3) Established research networks comprising familiar peers and institu-
tions may affect the ratings of scientiﬁc work. Since our ﬁndings
imply that also among western nations the per-capita GDP is a
strong predictor of the dissemination of research, other reasons as-
sociated with the origin of the respective studies may affect manu-
script selection during peer review and editorial decision-making.
Such a reason may simply be a natural skepticism towards studies
performed by unknown researchers or institutions. In this context
a double-blinded peer review process, where authors and their afﬁl-
iations are masked, may decrease a systematic manuscript selection
bias.
Taken together, the challenges faced by investigators in less wealthy
nations in disseminating their research do not appear to arise only from
educational disadvantages. The limited relevance of studies performed
under different environmental conditions in an ethnically different pop-
ulation also only insufﬁciently explains the results of this study. A natu-
ral manuscript selection bias, providing an advantage to scientists and
institutions familiar to reviewers and editors, may exist.
At this stage, however, it can only be speculated about the exact rea-
sons for the strong predictive value of the wealth of nations for the dis-
semination of research.
4.5. Potential implications
Researchers, publishers, editors, and organizing committees of
scientiﬁc meetings should join forces to overcome putative structural
disadvantages of less wealthy nations, increase the availability and dis-
semination of existing scientiﬁc information, and diminish manuscript
selection bias. Possible means to achieve these goals comprise to foster
international collaborations, encouraged through targeted funding by
global funding institutions, to consider double-blinded peer review pro-
cesses, and to continue encouraging open-source publishing.
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